QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

NCT01834235 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

81

Enrollment

INDUSTRY

Sponsor class

Stopped DSMB terminated the trial for futility.

Conditions

Pancreatic Cancer, Adult

Interventions

DRUG: Gemcitabine
DRUG: nab-paclitaxel
DRUG: NPC-1C

Sponsor

Precision Biologics, Inc